Celldex Therapeutics (CLDX) Selling, General & Administrative (2010 - 2026)
Celldex Therapeutics (CLDX) posted Selling, General & Administrative of $13.1 million for Q2 2026, up 26.1% from $10.39 million a year earlier and up 14.4% from the prior quarter.
Powered by 
Analysis
Celldex Therapeutics (CLDX) Selling, General & Administrative (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at Celldex Therapeutics was $47.18 million, up 13.6% year-over-year; for FY2025, it was $43.84 million, up 13.7% from FY2024.
- Annual Selling, General & Administrative has increased for five consecutive years, with a five-year compound annual growth rate of 24.8% (FY2020 to FY2025).
- In prior years, Celldex Therapeutics' Selling, General & Administrative was $38.55 million in FY2024 (+24.7%), $30.91 million in FY2023 (+13.7%), $27.2 million in FY2022 (+32.7%) and $20.49 million in FY2021 (+41.7%).
- The Q2 2026 figure stands as the highest quarterly Selling, General & Administrative in data going back to Q2 2010.
- On a year-over-year basis, Selling, General & Administrative has increased in each of the last 13 quarters, with growth averaging 15.7% over the last eight quarters.
- The strongest year-over-year quarter for Selling, General & Administrative in the past five years was Q4 2021, with growth of 72.3%; the weakest was Q1 2023, with a decline of 3.9%.
- According to Business Quant data, Selling, General & Administrative for the three prior quarters was $11.45 million (Q1 2026), $11.94 million (Q4 2025) and $10.69 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Celldex Therapeutics | 2.53 Bn | 2.53 Bn | - | 13.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.10 Mn |
| Mar 31, 2026 | 11.45 Mn |
| Dec 31, 2025 | 11.94 Mn |
| Sep 30, 2025 | 10.69 Mn |
| Jun 30, 2025 | 10.39 Mn |
| Mar 31, 2025 | 10.82 Mn |
| Dec 31, 2024 | 10.26 Mn |
| Sep 30, 2024 | 10.05 Mn |
| Jun 30, 2024 | 9.13 Mn |
| Mar 31, 2024 | 9.10 Mn |
| Dec 31, 2023 | 8.83 Mn |
| Sep 30, 2023 | 8.22 Mn |
| Jun 30, 2023 | 7.22 Mn |
| Mar 31, 2023 | 6.64 Mn |
| Dec 31, 2022 | 6.60 Mn |
| Sep 30, 2022 | 6.53 Mn |
| Jun 30, 2022 | 7.15 Mn |
| Mar 31, 2022 | 6.91 Mn |
| Dec 31, 2021 | 6.24 Mn |
| Sep 30, 2021 | 5.82 Mn |
API Access
Celldex Therapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=CLDX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "CLDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=CLDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();